Nervana

Nervana Therapeutics is an early-stage biotechnology company developing regenerative technologies for peripheral nerve repair. The company appears to be centered on its Cellularized Nerve Regeneration Graft (CNRG), a biodegradable scaffold-based implant designed to improve nerve regeneration after peripheral nerve injury. Publicly available information links the effort to Rutgers-affiliated inventors and translational programs, suggesting an academic spinout or commercialization project rather than a mature operating biotech. Its approach combines biomaterials, hydrogel matrix engineering, and patient-derived or cultured cells to support axonal regrowth and functional recovery. Based on available evidence, the company is preclinical and focused on translating a single core nerve-regeneration platform toward surgical use.